Frankfurt - Delayed Quote EUR

IRADIMED CORPORATION (46K.F)

51.00
+5.60
+(12.33%)
At close: May 30 at 8:01:50 AM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Roger E. Susi Founder, Chairman, CEO & President 607.85k -- 1953
Mr. John F. Glenn CFO & Corporate Secretary 506.69k -- 1962
Mr. Jeff Chiprin Chief Commercial Officer 92.94k -- 1966
Mr. Randy Waddell Vice President of Worldwide Sales & Marketing 393.27k -- --
Mr. Chris Williamson Executive Vice President of Continuous Improvement & Information Technology -- -- --
Mr. Matt Garner Controller -- -- --
Mr. Lynn Neuhardt Vice President of Research & Development 312.88k -- --

IRADIMED CORPORATION

1025 Willa Springs Drive
Winter Springs, FL 32708
United States
407 677 8022 https://www.iradimed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
160

Description

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Corporate Governance

IRADIMED CORPORATION’s ISS Governance QualityScore as of May 1, 2025 is 7. The pillar scores are Audit: 7; Board: 10; Shareholder Rights: 4; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 31, 2025 at 5:00 AM UTC

IRADIMED CORPORATION Earnings Date

Recent Events

May 20, 2025 at 12:00 AM UTC

Ex-Dividend Date